HOME >> BIOLOGY >> NEWS
Press registration -- World Congress of Nephrology, April 21-25, 2007, Rio de Janeiro, Brazil

The World Congress of Nephrology (April 21-25, 2007, Rio de Janeiro, Brazil) represents a unique opportunity for the global nephrology community to come together, share and exchange ideas, and collectively address current and future challenges faced by renal clinicians and scientists.

Updating on all aspects of basic and clinical research and care of renal patients, one of the many highlights for each day's program will be the keynote lectures to be given by a series of five outstanding scientists and clinicians covering several of the hottest topics in renal science and medicine.

Timely exchange and debate will surround the future applications of medical genetics to kidney disease, systems biology and the promise of personalized medicine, and hypoxia and hypoxia-inducible factors. Three clinical topics of particular interest will cover the connection between the kidney and cardiovascular disease, the current status of halting progression in diabetic nephropathy, and the often controversial issue of organ donation and allocation.

The core scientific program for WCN 2007 is divided into eight themes with over 70 individual symposia and some 300 invited speakers that will present topics of key interest to both clinicians and investigators. The themes (Molecular and Cell Biology and Physiology, Vascular Biology, Inflammation and Immunology and Pathology, Developmental Genetics and Pediatrics, General Clinical Nephrology, Acute Renal Failure, Chronic Kidney Disease, Diabetes and Hypertension, ESRD-dialysis, and Transplantation) will deliver the very latest advances in both clinical and basic research as well as updates on clinical care.

Interactive case discussions are part of several themes as well as sessions devoted to exciting abstracts of new research findings. Throughout the meeting over 2000 poster presentations will also take place another key element that will enhance your participation.

Press passes are limited and are o
'"/>

Contact: Amanda Wren
amanda.wren@isn-online.org
322-743-1546
International Society of Nephrology
13-Mar-2007


Page: 1 2

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. American Chemical Societys Weekly PressPac -- Aug. 1, 2007
3. American Chemical Societys Weekly PressPac -- July 25, 2007
4. American Chemical Societys Weekly PressPac -- July 18, 2007
5. American Chemical Societys Weekly PressPac -- July 11, 2007
6. American Chemical Societys Weekly PressPac -- June 27/July 3, 2007
7. American Chemical Societys Weekly PressPac -- June 20, 2007
8. American Chemical Societys Weekly PressPac -- June 13, 2007
9. Cell Press announces new partnership with the American Society of Human Genetics
10. American Chemical Societys Weekly PressPac -- May 30, 2007
11. ACS News Service Weekly PressPac -- May 23, 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... 27, 2020 , ... CrucialTrak, a global designer and manufacturer of biometric access ... (CEG) to market and sell its complete line of biometric readers and access ... infrastructure optimization solutions . , Brett Mason, CrucialTrak’s Director of Channel Sales for ...
(Date:5/28/2020)... ... May 28, 2020 , ... Actuate Therapeutics, ... their 1801 Phase 1/2 study (NCT03678883, EudraCT #: 2018-003739-32) will be presented at ... place virtually on May 29th, 2020. Dr. Benedito Carneiro, Brown University’s principal investigator ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... background and medical screening, announces the launch of a testing service aimed ... safe. The new service is provided by ClearStar’s Medical Information Services (“MIS”) ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... 23, 2020 , ... Kerafast Inc. , developers of ... the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, ... SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) ...
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen Pharmaceuticals Inc., announced today ... 22-24 during the American Association for Cancer Research Virtual meeting. One poster describes ... consistent single agent activity in KEAP1 mutant tumor models of NSCLC. ...
(Date:6/11/2020)... ... , ... Greffex, a leading genetic engineering company, with the ... vectors, recently announced a key manufacturing agreement with FUJIFILM Diosynth Biotechnologies to produce ... successful gene therapy delivery vehicle (vector) with broad applications for delivering treatments including ...
(Date:6/11/2020)... ... 2020 , ... Reducing carbon emissions has been and will continue to be ... market dips, ways to reduce CO2 is something we can’t avoid. , To ... biofuels being produced today are created from recycled cooking oil or crops. Unfortunately, these ...
Breaking Biology Technology:
Cached News: